Bain Capital Life Sciences Investors, LLC Xilio Therapeutics, Inc. Transaction History
Bain Capital Life Sciences Investors, LLC
- $662 Million
- Q1 2024
A detailed history of Bain Capital Life Sciences Investors, LLC transactions in Xilio Therapeutics, Inc. stock. As of the latest transaction made, Bain Capital Life Sciences Investors, LLC holds 2,805,413 shares of XLO stock, worth $2.52 Million. This represents 0.46% of its overall portfolio holdings.
Number of Shares
2,805,413
Previous 2,805,413
-0.0%
Holding current value
$2.52 Million
Previous $1.54 Million
96.43%
% of portfolio
0.46%
Previous 0.19%
Shares
1 transactions
Others Institutions Holding XLO
# of Institutions
32Shares Held
10MCall Options Held
0Put Options Held
0-
River Vest Venture Management LLC St. Louis, MO1.44MShares$1.3 Million19.12% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD1.44MShares$1.3 Million0.04% of portfolio
-
Atlas Venture Life Science Advisors, LLC993KShares$893,6200.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA903KShares$812,2770.0% of portfolio
-
Aju Ib Investment Co., Ltd. Seoul, M5668KShares$600,9673.33% of portfolio
About Xilio Therapeutics, Inc.
- Ticker XLO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,471,600
- Market Cap $24.7M
- Description
- Xilio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies to improve the immune system of cancer patients. Its checkpoint inhibitor program includes XTX101, a clinical-stage, tumor-selective anti-CTLA-4 mAb that is in Phase 1/2 clinical trials in patients with solid tumors. The company also develops cytokine prog...